Form 8-K - Current report:
SEC Accession No. 0000950170-21-005044
Filing Date
2021-12-06
Accepted
2021-12-06 07:55:54
Documents
12
Period of Report
2021-12-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211206.htm   iXBRL 8-K 75295
  Complete submission text file 0000950170-21-005044.txt   207151

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211206_lab.xml EX-101.LAB 19138
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211206.xsd EX-101.SCH 2495
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211206_pre.xml EX-101.PRE 11504
5 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211206_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211472016
SIC: 2834 Pharmaceutical Preparations